Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Amicus Therapeutics Inc
FOLDCurrent price
11.1 USD
-0.03 USD (-0.27%)
Last closed
11.22 USD
Company
amicusrx.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
3 290 220 288 USD
Yield for 12 month
-10.27 %
Week
Month
Year
FOLD
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. The company also develops AT-GAA, a novel treatment paradigm for Pompe disease; and enzyme replacement therapies for Pompe diseases. It has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. The company was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania. Address: 3675 Market Street, Philadelphia, PA, United States, 19104
Analytics
WallStreet Target Price
18 USDP/E ratio
–Dividend Yield
3.1 %Current Year
+329 233 000 USD
Last Year
+305 514 000 USD
Current Quarter
+103 501 000 USD
Last Quarter
+94 503 000 USD
Current Year
+290 634 000 USD
Last Year
+271 048 000 USD
Current Quarter
+93 555 000 USD
Last Quarter
+85 389 000 USD
Key Figures FOLD
1 year
3 years
5 years
10 years
EBITDA
-103 544 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-9.07 %
PEG Ratio
-0.18
Return On Equity TTM
-130.63 %
Wall Street Target Price
18 USD
Revenue TTM
372 369 984 USD
Book Value
0.46 USD
Revenue Per Share TTM
1.27 USD
Dividend Share
–
Quarterly Revenue Growth YOY
26.7 %
Dividend Yield
3.1 %
Gross Profit TTM
290 634 000 USD
Earnings Share
-0.59 USD
Diluted Eps TTM
-0.59 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
-46.62 %
Dividend Analytics FOLD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History FOLD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
3.1 %
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation FOLD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
60.6061
Enterprise Value Revenue
9.2953
Price Sales TTM
8.8359
Enterprise Value EBITDA
-26.0049
Price Book MRQ
24.6725
Financials FOLD
1 year
3 years
5 years
10 years
| Results | 2019 | Dynamics |
Technical indicators FOLD
For 52 weeks
9.7 USD
14.1 USD
50 Day MA
10.99 USD
Shares Short Prior Month
22 555 682
200 Day MA
11.98 USD
Short Ratio
8.83
Shares Short
22 728 241
Short Percent
7.79 %
Google
Apple
Facebook